ENDRA Life Sciences (NDRA) Change in Receivables (2017 - 2018)
ENDRA Life Sciences (NDRA) reported Change in Receivables of -$12275.0 for Q4 2018, down 279.2% year-over-year from $6850.0 in Q4 2017, and down 2530.69% quarter-over-quarter from $505.0 in Q3 2018.
ENDRA Life Sciences (NDRA) Change in Receivables (2017 - 2018) Analysis & Trends
ENDRA Life Sciences (NDRA) has 2 years of Change in Receivables data on file, last reported at -$12275.0 in Q4 2018.
- Change in Receivables for Q4 2018 came in at -$12275.0, down 279.2% year-over-year; the trailing twelve-month figure through Sep 2019 was -$12275.0 (down 200.0% YoY), and the FY2018 annual result was -$6850.0, down 200.0% from the prior year.
- Change in Receivables declined to -$12275.0 in Q4 2018 per NDRA's latest filing, from $505.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $6850.0 in Q4 2017 and troughed at -$12275.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | - |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | -12.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 121.07 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -65.11 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -12,275.00 |
| Dec 31, 2018 | -12,275.00 |
| Sep 30, 2018 | 505.00 |
| Sep 30, 2018 | 505.00 |
| Mar 31, 2018 | 4,920.00 |
| Mar 31, 2018 | 4,920.00 |
| Dec 31, 2017 | 6,850.00 |
| Dec 31, 2017 | 6,850.00 |